Q2 Earnings Estimate for ACAD Issued By Leerink Partnrs
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Analysts at Leerink Partnrs upped their Q2 2025 earnings estimates for shares of ACADIA Pharmaceuticals in a research note issued to investors on Sunday, April 13th. Leerink Partnrs analyst M. Goodman now forecasts that the biopharmaceutical company will earn $0.21 per share for the quarter, up from […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Analysts at Leerink Partnrs upped their Q2 2025 earnings estimates for shares of ACADIA Pharmaceuticals in a research note issued to investors on Sunday, April 13th. Leerink Partnrs analyst M. Goodman now forecasts that the biopharmaceutical company will earn $0.21 per share for the quarter, up from […]
